Molecular Therapy — Nucleic Acids · 2019 · 61 citations · 47 references
MedicineMolecular BiologyOncologyMolecular OncologyOncogenesTumor ProgressionCancer ProgressionMicrorna BiologyMicrorna-mediated RegulationNoncoding Rna In CancerPancreatic CancerTumor Suppressor GenesCell Cycle Arrest MechanismsHalf-maximal Inhibitory ConcentrationMicrorna Function In CancerMicrorna In CancerMicrorna Regulation In CancerMicrorna TargetingMicrorna TherapyMicrorna-mediated Oncogenesis
) more than 6.5-fold. To investigate the therapeutic potential of miR-15a, we used a modified miR-15a (5-FU-miR-15a) with uracil (U) residues in the guide strand replaced with 5-fluorouracil (5-FU). We demonstrated enhanced inhibition of PDAC cell proliferation by 5-FU-miR-15a compared to native miR-15a. In vivo we showed the therapeutic power of 5-FU-miR-15a alone or in combination with gemcitabine with near complete elimination of PDAC lung metastatic tumor growth. These results support the future development of 5-FU-miR-15a as a novel therapeutic agent as well as a prognostic biomarker in the clinical management of PDAC.
47
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
Ulrich K. Laemmli · Nature · 1970 · 251.6K citations
Rebecca L. Siegel, Kimberly D. Miller, Ahmedin Jemal · CA A Cancer Journal for Clinicians · 2019 · 21K citations · Full text
George A. Calin, Calin Dan Dumitru, Masayoshi Shimizu et al. · Proceedings of the National Academy of Sciences · 2002 · 5K citations · Full text